Professor Michael Henson, a faculty member in the Chemical Engineering Department at the University of Massachusetts Amherst, is the principal investigator for a three-university collaborative project, which involves creating mathematical models of “circadian rhythm” generation to better understand sleep disorders and other diseases triggered by the malfunction of this 24-hour “body clock” in humans. The research is being supported by a very significant, four-year, $1,809,385 grant from the National Institutes of Health (NIH).
UMass Amherst Chemical Engineering alumna Dr. Sarena Horava, now employed at Triton Systems of Chelmsford, Massachusetts, was the lead author of an article published in the November 30 issue of the International Journal of Pharmaceutics that describes groundbreaking research leading to the first-ever capsule to treat hemophilia. Horava worked on the historic process during her doctoral studies at the University of Texas Austin Cockrell School of Engineering, where she collaborated with Nicholas A. Peppas, the director of UT Austin’s Institute for Biomaterials, Drug Delivery, and Regenerative Medicine and a Cockrell School professor.
UMass Chemical Engineering alumna Christine Seymour, the director in Global Regulatory Chemistry and Manufacturing Controls at Pfizer Inc, has been chosen as the president elect of the American Institute of Chemical Engineers (AIChE) and will take office in 2018. Dr. Seymour will also serve on the AIChE Board of Directors in 2017.